Difficulty: Medium
Average Score: 77%
Practice
Which of the following antimuscarinic drugs is a selective MÔéü blocker?
Correct answer
C
Rationale
The correct answer is C) Pirenzepine. Pirenzepine is a selective MÔéü blocker because it specifically targets the MÔéü muscarinic receptor subtype. This selectivity makes it different from the other options provided.
Atropine (A) is a non-selective antimuscarinic drug that blocks all muscarinic receptor subtypes (MÔéü, MÔéé, MÔéâ, MÔéä, MÔéà). Scopolamine (B) is also a non-selective antimuscarinic drug, like atropine, acting on all muscarinic receptor subtypes.
Homatropine (D) is mainly used for its mydriatic effects in ophthalmic procedures and is not known for its selectivity for the MÔéü receptor subtype.
Educationally, understanding the selectivity of antimuscarinic drugs is crucial in pharmacology. Knowing the specific receptor subtype targeted by a drug can help predict its effects and side effects. In clinical practice, selecting the appropriate antimuscarinic drug based on its receptor selectivity can lead to more targeted and effective treatment strategies.
Atropine (A) is a non-selective antimuscarinic drug that blocks all muscarinic receptor subtypes (MÔéü, MÔéé, MÔéâ, MÔéä, MÔéà). Scopolamine (B) is also a non-selective antimuscarinic drug, like atropine, acting on all muscarinic receptor subtypes.
Homatropine (D) is mainly used for its mydriatic effects in ophthalmic procedures and is not known for its selectivity for the MÔéü receptor subtype.
Educationally, understanding the selectivity of antimuscarinic drugs is crucial in pharmacology. Knowing the specific receptor subtype targeted by a drug can help predict its effects and side effects. In clinical practice, selecting the appropriate antimuscarinic drug based on its receptor selectivity can lead to more targeted and effective treatment strategies.